Transport Across the Primate Blood-Brain Barrier of a Genetically Engineered Chimeric Monoclonal Antibody to the Human Insulin Receptor
- 1 January 2000
- journal article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 17 (3) , 266-274
- https://doi.org/10.1023/a:1007592720793
Abstract
Purpose. Brain drug targeting may be achieved by conjugating drugs,that normally do not cross the blood-brain barrier (BBB), to brain drugdelivery vectors. The murine 83-14 MAb to the human insulin...Keywords
This publication has 26 references indexed in Scilit:
- An Antibody-Avidin Fusion Protein Specific for the Transferrin Receptor Serves as a Delivery Vehicle for Effective Brain Targeting: Initial Applications in Anti-HIV Antisense Drug Delivery to the BrainThe Journal of Immunology, 1999
- Vector-mediated drug delivery to the brainAdvanced Drug Delivery Reviews, 1999
- CNS Drug Design Based on Principles of Blood‐Brain Barrier TransportJournal of Neurochemistry, 1998
- Drug targeting of a peptide radiopharmaceutical through the primate blood-brain barrier in vivo with a monoclonal antibody to the human insulin receptor.Journal of Clinical Investigation, 1997
- Human insulin receptor monoclonal antibody undergoes high affinity binding to human brain capillaries in vitro and rapid transcytosis through the blood-brain barrier in vivo in the primate.Pharmaceutical Research, 1995
- Development and in vitro Characterization of a Cationized Monoclonal Antibody against βA4 Protein: A Potential Probe for Alzheimer's DiseaseBioconjugate Chemistry, 1994
- Blood-brain barrier transcytosis of insulin in developing rabbitsBrain Research, 1987
- Human Blood—Brain Barrier Insulin ReceptorJournal of Neurochemistry, 1985
- Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains.Proceedings of the National Academy of Sciences, 1984
- Isolated microvessels: the blood-brain barrier in vitro.Proceedings of the National Academy of Sciences, 1978